Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

s_hhs_2017a_2017-04-05t10:22:16z0 Hearing Summary

Date: 04/05/2017

Location: SCR 354

Final

BILL SUMMARY for HB17-1224



SENATE COMMITTEE ON HEALTH & HUMAN SERVICES


Votes: View--> Action Taken:
Refer House Bill 17-1224 to the Committee of the W PASS







10:22 AM -- HB 17-1224



Senator Gardner, bill sponsor, presented House Bill 17-1224. As amended by the House Committee on Business Affairs and Labor, this bill amends the pharmacy practice law to make unlawful the possession, sale, dispensing, giving, receiving, or administering of a drug or device that is adulterated or misbranded as defined by the Colorado Food and Drug Act. The bill creates a new civil penalty of $1,000 to $10,000 for any unlawful act under the pharmacy practice law, including the violations created by this bill. Revenue from this penalty is deposited into the General Fund.





10:31 AM --
Anne McGihon, Allergan, testified in support of the bill.

BILL: HB17-1224
TIME: 10:38:29 AM
MOVED: Kefalas
MOTION: Refer House Bill 17-1224 to the Committee of the Whole with a recommendation for the consent calendar. The motion passed on a vote of 5-0.
SECONDED:
VOTE
Aguilar
Yes
Crowder
Yes
Kefalas
Yes
Martinez Humenik
Yes
Smallwood
Yes
Final YES: 5 NO: 0 EXC: 0 ABS: 0 FINAL ACTION: PASS














The effective date for bills enacted without a safety clause is August 6, 2025, if the General Assembly adjourns sine die on May 7, 2025 (unless otherwise specified). Details

Request for Proposal for the COYAC Contract. Details

Our website is currently undergoing a redesign in order to provide a better experience for everyone. View the Beta site